Delivery Order SPE2DB20D2014-SPE2DB24FC35U

Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,342.11 firm fixed-price delivery order contract is for the supply of CELLCEPT 500 MG TABLET 100S, a prescription medication. The contract has an ultimate completion date of February 20, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,805.39 firm fixed-price delivery order contract is for the supply of CELLCEPT 500 MG TABLET 100S to support federal healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with a Ceiling Value of $9,218.84. The contract is for the delivery of CELLCEPT 500 MG TABLET 100S and is a Firm Fixed Price contract type. The ultimate completion date for this order is July 9, 2024. Amerisourcebergen Drug Corp holds a larger IDC with the DLA Troop...
This federal contract award is a delivery order valued at $22,275.47, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of CELLCEPT 500 MG TABLET 100S, a prescription medication, with a performance period extending through May 20, 2025. The contract is noted as having no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,786.52 fixed-price delivery order is for the supply of CELLCEPT 200 MG/ML ORAL SUSP 160ML, a medical product, with a completion date of January 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,651.91 firm-fixed-price delivery order contract is for the supply of 4,568,039,684 units of CELLCEPT 500 MG TABLET 500S, a medication used for organ transplant patients. The contract has an ultimate completion date of April 28, 2025. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,147.27 firm fixed-price delivery order is for the supply of CELLCEPT 500 MG TABLET 500S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,031.00 firm fixed price delivery order is for the supply of CELLCEPT 500 MG TABLET 100S, a medication used in the management of certain medical conditions. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award, identified as SPE2DB20D1100|SPE2DB25FC0K1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract, valued at $11,061.15, is a delivery order for the supply of 4,568,092,149 units of the medication CELLCEPT 500 MG TABLET 100S. The contract is a firm fixed-price arrangement with a performance period through May 1, 2025....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,036.59, is for the delivery of CELLCEPT 500 MG TABLET 500S, a pharmaceutical product, with a completion date of May 20, 2025. The award is not set aside and involves open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC35U
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $2,325.88 firm fixed price delivery order is for the supply of 4,565,031,462 units of CellCept 500 mg tablets.

Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This delivery order appears to be placed against that larger IDC vehicle.

The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/27/24, 9:27 AM